Cited by 281Allergic Rhinitis and SensitizationFood Allergy and Anaphylaxis ResearchAsthma and respiratory diseases

The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study

Open access

Purello‐D'Ambrosio, F., Gangemi, S., Merendino, R. A., Isola, S., Puccinelli, P., Parmiani, S., Ricciardi, L.·2001·Clinical & Experimental Allergy

DOI 10.1046/j.1365-2222.2001.01027.x

Open this paper in CoChat — free account Open PDF

Abstract

Background Specific immunotherapy is the only currently available allergen‐orientated treatment able to modify the natural history of respiratory allergic diseases. Safety and clinical efficacy of this treatment are well documented, but evidence about the ability to reduce new sensitizations is still poor. Objective We report a retrospective study conducted in order to assess the prevention of new sensitizations in monosensitized subjects treated with specific immunotherapy vs. monosensitized patients treated with anti‐allergic drugs. Methods 8396 monosensitized patients with respiratory symptoms were selected according to an open, retrospective design. Group A included 7182 patients submitted to specific immunotherapy (and anti‐allergic drugs when needed) for 4 years and then treated with drugs for at least 3 years. Group B included 1214 patients treated only with drugs for at least 7 years. All patients underwent prick test with a standard panel of allergens and total and specific IgE determination before and after 4 years of treatment and again 3 years later. Results Groups were well balanced. Polysensitized subjects were 23.75% in Group A and 68.03% in Group B after 4 years (P < 0.0001) and 26.95% and 76.77%, respectively, after 7 years (P < 0.0001). Asthmatic subjects were more prone to develop polysensitization in comparison to subjects suffering only from rhinitis (32.14% instead of 27.29% after 4 years, 36.5% instead of 31.33% after 7 years; P < 0.0001). Specific IgE decreased by 24.11% in Group A and increased by 23.87% in Group B (P < 0.0001). Total IgE decreased by 17.53% in Group A and increased by 13.71% in Group B (P < 0.0001). Conclusions Specific immunotherapy was observed retrospectively to reduce new sensitizations in monosensitized subjects suffering from respiratory allergic diseases.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1046/j.1365-2222.2001.01027.x

Cites

76 of 76 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Long-Term Clinical Efficacy of Grass-Pollen Immunotherapy
Durham, S. R., Walker, S. M., Varga, E., Jacobson, M. R., O'Brien, F., Noble, W. J., Till, S. J., Hamid, Q. A., & Nouri‐Aria, K. T. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410702 · Cited by 1,371
PROPHYLACTIC INOCULATION AGAINST HAY FEVER
Noon, L. (1911) · The Lancet · doi:10.1016/s0140-6736(00)78276-6 · Cited by 1,343
Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells.
Punnonen, J., Aversa, G., Cocks, B. G., McKenzie, A. N., Menon, S., Zurawski, G., Malefyt, R. D. W., & de Vries, J. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3730 · Cited by 1,101
Recombinant human interleukin 5 is a selective activator of human eosinophil function.
Lopez, A. F., Sanderson, C. J., Gamble, J. R., Campbell, H. D., Young, I., & Vadas, M. A. (1988) · The Journal of Experimental Medicine · doi:10.1084/jem.167.1.219 · Cited by 949
Allergen Immunotherapy: Therapeutic Vaccines for Allergic Diseases
Bousquet, J., Lockey, R. F., Malling, H., Álvarez-Cuesta, E., Canonica, G. W., Chapman, M. D., Creticos, P. S., Dayer, J., Durham, S. R., Demoly, P. M., et al. (1998) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)63136-5 · Cited by 739
IL-4 is an essential factor for the IgE synthesis induced in vitro by human T cell clones and their supernatants.
Prete, G. D., Maggi, E., Parronchi, P., Chrétien, I., Tiri, A., Macchia, D., Ricci, M., Banchereau, J., de Vries, J. E., & Romagnani, S. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.12.4193 · Cited by 707
Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children
Roches, A. D., Paradis, L. P., Ménardo, J.-L., Bouges, S., Daurès, J., & Bousquet, J. (1997) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(97)70069-1 · Cited by 572
Interleukin 4 is localized to and released by human mast cells.
Bradding, P. H., Feather, I. H., Howarth, P. H., Mueller, R., Roberts, J. A., Britten, K. M., Bews, J. P. A., Hunt, T. C., Okayama, Y., & Heusser, C. (1992) · The Journal of Experimental Medicine · doi:10.1084/jem.176.5.1381 · Cited by 571
Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals.
Secrist, H., Chelen, C. J., Wen, Y., Marshall, J. D., & Umetsu, D. T. (1993) · The Journal of Experimental Medicine · doi:10.1084/jem.178.6.2123 · Cited by 539
Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison.
von Mutius, E., Fritzsch, C., Weiland, S. K., Röll, G., & MAGNUSSEN, H. (1992) · BMJ · doi:10.1136/bmj.305.6866.1395 · Cited by 503

Show all 76 references

Research works printed but not linked: 4

Jacobsen L, 1995, Proceedings of the XVI European Congress of Allergology and Clinical Immunology., 145
D'Amato G, 1991, Variazioni antigeniche nei ceppi e nei lotti di Alternaria isolati in Ann Arbor e in Napoli, G Ital Allergol Immunol Clin, 1, 133
Ebner C, 1997, a major grass pollen allergen, Clin Exp Allergy, 27, 1
Des Roches A, 1995, Specific immunotherapy prevents the onset of new sensitizations in monosensitized children. [Abstract], J Allergy Clin Immunol, 95, 309

Sorted by citations

Items 101–200 of 280

3-years' long-term effect of subcutaneous immunotherapy (SCIT) with a high-dose hypoallergenic 6-grass pollen preparation in adults.
Dominicus, R. (2012) · PubMed · Cited by 25
Allergen‐specific immunotherapy alters the expression of B and T lymphocyte attenuator, a co‐inhibitory molecule, in allergic rhinitis
Okano, M., Otsuki, N., Azuma, M., Fujiwara, T., Kariya, S., Sugata, Y., Higaki, T., Kino, K., Tanimoto, Y., Okubo, K., et al. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.03116.x · Cited by 25
Immunotherapy for Inhalant Allergens
Nelson, H. S. (2009) · Elsevier eBooks · doi:10.1016/b978-0-323-05659-5.00095-4 · Cited by 25
Guidelines for practice of Allergen Immunotherapy in India
Gaur, S. N. S., Singh, B., Singh, A., Vijayan, V. K., & Agarwal, M. (2009) · Cited by 24
Long-Term Immunologic Effects of Broad-Spectrum Aeroallergen Immunotherapy
Limb, S. L., Brown, K. C., Wood, R. A., Eggleston, P. A., Hamilton, R. G., & Adkinson, N. F. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000093250 · Cited by 24
The Current State of Epicutaneous Immunotherapy for Food Allergy: a Comprehensive Review
Lanser, B. J., & Leung, D. Y. M. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8650-3 · Cited by 23
Preventive sublingual immunotherapy with House Dust Mite extract modulates epitope diversity in pre‐school children
Ponce, M., Schroeder, F., Bannert, C., Schmidthaler, K., Hansen, C. S., Bøgh, K. L., Soldo, R., Tsui, S. K., Weinhäusel, A., Szépfalusi, Z., et al. (2018) · Allergy · doi:10.1111/all.13658 · Cited by 23
The Allergic March in Pollinosis: Natural History and Therapeutic Implications
Marogna, M., Falagiani, P., Bruno, M., Massolo, A., & Riva, G. (2004) · International Archives of Allergy and Immunology · doi:10.1159/000082329 · Cited by 23
Emerging drugs for allergic conjunctivitis
Ridolo, E., Montagni, M., Caminati, M., Senna, G., Incorvaia, C., & Canonica, G. W. (2014) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2014.902443 · Cited by 22
Allergen Delivery Inhibitors: A Rationale for Targeting Sentinel Innate Immune Signaling of Group 1 House Dust Mite Allergens through Structure-Based Protease Inhibitor Design
Zhang, J., Chen, J., Newton, G. K., Perrior, T. R., & Robinson, C. (2018) · Molecular Pharmacology · doi:10.1124/mol.118.112730 · Cited by 23
Development of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy.
Gülen, F., Zeyrek, D., Can, D., Altınöz, S., Köksoy, H., Demir, E., & Tanaç, R. (2007) · PubMed · Cited by 22
Injection Immunotherapy with Different Airborne Allergens Did Not Prevent de novo Sensitization to Ragweed and Birch Pollen North of Milan
Asero, R. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000075253 · Cited by 21
Sublingual immunotherapy and allergic rhinitis
Cox, L. (2008) · Current Allergy and Asthma Reports · doi:10.1007/s11882-008-0019-5 · Cited by 20
Further marches: allergic and non‐allergic
Scadding, G. K. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02675.x · Cited by 20
Oral and sublingual immunotherapy in paediatric patients
Passalacqua, G., Baena‐Cagnani, C. E., Berardi, M., & Canonica, G. W. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200304000-00008 · Cited by 20
Allergic rhinitis
Astafieva, N. G., Aa, B., Vishneva, Е. A., Дайхес, Н. А., Zhestkov, A. V., Ilyina, N. I., Витальевна, К. О., Karpova, E. P., Kim, I. A., Kryukov, A. I., et al. (2020) · Russian Rhinology · doi:10.17116/rosrino202028041246 · Cited by 19
Effects of established allergen sensitization on immune and airway responses after secondary allergen sensitization
Blümchen, K., Gerhold, K., Schwede, M., Niggemann, B., Avagyan, A., Dittrich, A., Wagner, B., Breiteneder, H., & Hamelmann, E. H. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.04.054 · Cited by 19
Evaluation of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy.
Harmancı, K., Razi, C. H., Toyran, M., Kanmaz, G., & Cengizlier, M. R. (2010) · PubMed · Cited by 18
Development of subcutaneous allergen immunotherapy (part 2): preventive aspects and innovations
Klimek, L., Brehler, R., Hamelmann, E. H., Kopp, M., Ring, J., Treudler, R., Jakob, T., Worm, M., & Pfaar, O. (2019) · Allergo Journal International · doi:10.1007/s40629-019-0097-z · Cited by 18
Specific allergen immunotherapy: effect on IgE, IgG4 and chemokines in patients with allergic rhinitis
Stylianou, E., Ueland, T., Borchsenius, F., Michelsen, A. E., Øvstebø, R., Mollnes, T. E., Skjønsberg, O. H., & Aukrust, P. (2016) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2015.1110856 · Cited by 18
Guidelines for practice of allergen immunotherapy in India: 2017-An update
Gaur, S., Kumar, R., Singh, A., Agarwal, M., & Arora, N. (2017) · Indian Journal of Allergy Asthma and Immunology · doi:10.4103/ijaai.ijaai_10_17 · Cited by 18
Randomized double-blind placebo-controlled trial of sublingual immunotherapy in children with house dust mite allergy in primary care: study design and recruitment
de Bot, C. M., Moed, H. D., Berger, M. Y., Röder, E., de Groot, H., de Jongste, J. C., van Wijk, R. G., & van der Wouden, J. C. (2008) · BMC Family Practice · doi:10.1186/1471-2296-9-59 · Cited by 17
Study of atopic multimorbidity in subjects with rhinitis using multiplex allergen component analysis
Blöndal, V., Sundbom, F., Borres, M. P., Högman, M., Alving, K., Malinovschi, A., & Janson, C. (2020) · Clinical and Translational Allergy · doi:10.1186/s13601-020-0311-6 · Cited by 17
Efficacy and safety of allergen immunotherapy in children
Nelson, H. S. (2006) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60894-0 · Cited by 17
Induction and Inhibition of the Th2 Phenotype Spread: Implications for Childhood Asthma
Hayashi, T., Gong, X., Rossetto, C. C., Shen, C., Takabayashi, K., Redecke, V., Spiegelberg, H. L., Broide, D. H., & Raz, E. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.9.5864 · Cited by 17
Preventive capacity of allergen immunotherapy on the natural history of allergy
Incorvaia, C. (2015) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2013.54.2.375 · Cited by 16
Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitis
Pfaar, O., Mösges, R., Hörmann, K., & Klimek, L. (2009) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-009-1077-6 · Cited by 16
Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient
Nelson, H. S. (2016) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2016.1237874 · Cited by 16
Allergen-specific Immunotherapy for Inhalant Allergens in Children
Caffarelli, C., Cangemi, J., Mastrorilli, C., Giannetti, A., & Ricci, G. (2019) · Current Pediatric Reviews · doi:10.2174/1573396315666191021104003 · Cited by 16
Undertreatment of allergy: Exploring the utility of sublingual immunotherapy
Emanuel, I. A., Parker, M. J., & Traub, O. (2009) · Otolaryngology · doi:10.1016/j.otohns.2009.01.023 · Cited by 16
SLIT’s Prevention of the Allergic March
Porcaro, F., Corsello, G., & Pajno, G. B. (2018) · Current Allergy and Asthma Reports · doi:10.1007/s11882-018-0785-7 · Cited by 16
Efficacy and safety of specific immunotherapy with a modified mite extract
Ferreira, M. B., Santos, A. S., Santos, M. C. P., Carlos, M., Barbosa, M. P., & CARLOS, A. G. P. (2005) · Allergologia et Immunopathologia · doi:10.1157/13072918 · Cited by 16
House dust mite allergic airway inflammation facilitates neosensitization to inhaled allergen in mice
van Rijt, L. S., Logiantara, A., Utsch, L., Canbaz, D., Boon, L., & van Ree, R. (2012) · Allergy · doi:10.1111/all.12017 · Cited by 15
Allergen Delivery Inhibitors: Characterisation of Potent and Selective Inhibitors of Der p 1 and Their Attenuation of Airway Responses to House Dust Mite Allergens
Zhang, J., Chen, J., Zuo, J., Newton, G. K., Stewart, M. R., Perrior, T. R., Garrod, D. R., & Robinson, C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19103166 · Cited by 15
Bystander Effect in Synergy to Anergy in Oral Tolerance of Blomia Tropicalis/Ovalbumin Murine Co-Immunization Model
Oliveira, C., Taniguchi, E. A. F., Fusaro, A. E., Victor, J. R., de Brito, C. A., Duarte, A. J. S., & Sato, M. N. (2005) · Journal of Clinical Immunology · doi:10.1007/s10875-005-2821-3 · Cited by 15
Sublingual and oral immunotherapy
Canonica, G. W., Compalati, E., Fumagalli, F., & Passalacqua, G. (2004) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2004.07.001 · Cited by 15
Consider the childHow early should we treat?
LIU, A. (2003) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2003.10.034 · Cited by 15
Allergen immunotherapy for the prevention of allergic disease: protocol for a systematic review
Dhami, S., Nurmatov, U. B., Halken, S., Calderón, M. A., Muraro, A. M., Roberts, G. C., Toit, G. D., Kleine‐Tebbe, J., Larenas‐Linnemann, D. E., Lau, S., et al. (2015) · Pediatric Allergy and Immunology · doi:10.1111/pai.12524 · Cited by 14
Dose-Dependent Immunological Responses after a 6-Month Course of Sublingual House Dust Mite Immunotherapy in Patients with Allergic Rhinitis
Didier, A. P., Campo, P., Moreno, F., Durand-Perdriel, F., Marín, A., & Chartier, A. (2015) · International Archives of Allergy and Immunology · doi:10.1159/000442467 · Cited by 14
De novo sensitization during subcutaneous allergen specific immunotherapy - an analysis of 51 cases of SCIT and 33 symptomatically treated controls
Gellrich, D., Eder, K., Högerle, C., Becker, S., Canis, M., & Gröger, M. (2020) · Scientific Reports · doi:10.1038/s41598-020-63087-4 · Cited by 14
Effects of specific immunotherapy on the development of new sensitisations in monosensitised patients
Tella, R., Bartra, J., Miguel, M. S., Olona, M., Bosque, M., Gaig, P., & García-Ortega, P. (2003) · Allergologia et Immunopathologia · doi:10.1016/s0301-0546(03)79182-4 · Cited by 13
Allergic rhinitis.Clinical practice guidelines.
Pavlova, K. S. (2022) · Russian Journal of Allergy · doi:10.36691/rja1524 · Cited by 12
Subcutaneous allergen immunotherapy in the treatment of allergic respiratory disease
Creticos, P. S. (2022) · Allergy and Asthma Proceedings · doi:10.2500/aap.2022.43.220033 · Cited by 12
The need for patient‐focused therapy for children and teenagers with allergic rhinitis: a case‐based review of current European practice
Santos, A. F., Borrego, L. M., Rotiroti, G., Scadding, G. K., & Roberts, G. C. (2015) · Clinical and Translational Allergy · doi:10.1186/s13601-014-0044-5 · Cited by 12
Injection Immunotherapy for Inhalant Allergens
Nelson, H. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-323-08593-9.00088-7 · Cited by 12
Allergen immunotherapy: immunomodulatory treatment for allergic diseases
Cox, L. (2006) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.2.4.533 · Cited by 12
Allergen Immunotherapy
Rank, M. A., & Li, J. T. C. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.9.1119 · Cited by 12
Tradition and innovation: Finding the right balance
Durham, S. R. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.02.034 · Cited by 11
Sublingual immunotherapy in children
van Wijk, R. G. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.3.291 · Cited by 11
Sublingual Immunotherapy for Allergic Rhinoconjunctivitis – The Seeming and the Real
Reider, N. (2005) · International Archives of Allergy and Immunology · doi:10.1159/000086329 · Cited by 11
Immunotherapy for rhinitis
Malling, H. (2003) · Current Allergy and Asthma Reports · doi:10.1007/s11882-003-0040-7 · Cited by 11
Peptide immunotherapy for allergic disease
Tarzi, M. D., & Larché, M. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.4.617 · Cited by 11
Guiding principles of subcutaneous immunotherapy for allergic rhinitis in Japan
Okamoto, Y., Ohta, N., Okano, M., Kamijo, A., Gotoh, M., Suzuki, M., Takeno, S., Terada, T., Hanazawa, T., Horiguchi, S., et al. (2013) · Auris Nasus Larynx · doi:10.1016/j.anl.2013.06.003 · Cited by 10
Sublingual Immunotherapy
Lin, S. Y., & Leatherman, B. D. (2011) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2011.03.012 · Cited by 10
Review on immunotherapy in airway allergen sensitised patients.
van der Valk, J. P. M., de Jong, N. W., & van Wijk, R. G. (2015) · PubMed · Cited by 10
Preventing new sensitization and asthma onset by allergen immunotherapy: the current evidence
Wahn, U. (2017) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000399 · Cited by 10
Real-Life Effect of a Microcrystalline Tyrosine Adjuvanted Mite Immunotherapy in Patients with Allergic Rhinitis
Roger, A., Malet, A., Moreno, V., Parra, A., Gutiérrez, D., Lleonart, R., Moreno, F., Valero, A., Navarro, B., Hinojosa, B., et al. (2020) · Immunotherapy · doi:10.2217/imt-2019-0205 · Cited by 10
Immunotherapy of allergic bronchopulmonary aspergillosis a clinical and experimental approach
Svirshchevskaya, E. V. (2003) · Frontiers in bioscience · doi:10.2741/996 · Cited by 10
Clinical efficacy and safety of coseasonal initiation of Artemisia annua sublingual immunotherapy on patients with Artemisia-induced rhinoconjunctivitis
Feng, Y., Cao, Y., Liu, Y., Wang, Q., He, C., Hao, J., Zhang, K., & Huangfu, H. (2023) · American Journal of Otolaryngology · doi:10.1016/j.amjoto.2023.103942 · Cited by 9
Upregulated levels of human β‐defensins in patients with seasonal allergic rhinitis after allergen‐specific immunotherapy treatment
Bogefors, J., Kvarnhammar, A. M., & Cardell, L. (2012) · International Forum of Allergy & Rhinology · doi:10.1002/alr.21127 · Cited by 9
Injection and Sublingual Immunotherapy in the Management of Allergies Affecting the Unified Airway
Leatherman, B. D. (2008) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2007.11.016 · Cited by 9
Therapeutic Effects and Biomarkers in Sublingual Immunotherapy: A Review
Fujimura, T., Okamoto, Y., & Taniguchi, M. (2012) · Journal of Allergy · doi:10.1155/2012/381737 · Cited by 9
Sublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews
de Bot, C. M. A., Moed, H. D., Berger, M. Y., Röder, E., van Wijk, R. G., & van der Wouden, J. C. (2011) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2011.01165.x · Cited by 9
Prévention secondaire et tertiaire de l’asthme allergique de l’enfant
Rancé, F., Deschildre, A., Bidat, É., Just, J., Couderc, L., Wanin, S., & Weiss, L. M. (2010) · Revue des Maladies Respiratoires · doi:10.1016/j.rmr.2010.06.024 · Cited by 9
Allergy immunotherapy prescribing trends for grass pollen-induced allergic rhinitis in Germany: a retrospective cohort analysis
McDonell, A. L., Wahn, U., Demuth, D., Richards, C., Hawes, C., Andreasen, J. N., & Allen‐Ramey, F. (2015) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-015-0085-x · Cited by 8
Blocking Antibody Is Generated in Allergic Rhinitis Patients during Specific Immunotherapy Using Standardized Japanese Cedar Pollen Extract
Kawakami, A., Koketsu, R., Suzukawa, M., Nagao, M., Hiraguchi, Y., Tokuda, R., Fujisawa, T., Nagase, H., Ohta, K., Yamamoto, K., et al. (2008) · International Archives of Allergy and Immunology · doi:10.1159/000126062 · Cited by 8
Evidence in immunotherapy for paediatric respiratory allergy: Advances and recommendations. Document of the Immunotherapy Working Group of the Spanish Society of Pediatric Clinical Immunology and Allergology (SEICAP)
Tortajada‐Girbés, M., del Castillo, M. M., Larramona, H., Lucas, J. M., Álvaro, M., Tabar, A. I., Jerez, M., & Martínez‐Cañavate, A. (2016) · Allergologia et Immunopathologia · doi:10.1016/j.aller.2016.09.001 · Cited by 8
Die spezifische Immuntherapie bei allergischer Rhinitis
Pfaar, O., & Klimek, L. (2008) · HNO · doi:10.1007/s00106-008-1732-z · Cited by 8
Management of allergic rhinitis
Cauwenberge, P. V., & Hoecke, H. V. (1989) · Inpharma Weekly · doi:10.1007/bf03319278 · Cited by 8
Visual analysis of allergic rhinitis in children based on web of science and CiteSpace software
Liu, F., Chen, N., Wang, R., Zhang, L., & Li, Y. (2022) · Frontiers in Pediatrics · doi:10.3389/fped.2022.911293 · Cited by 7
Sensitization to Inhaled Ryegrass Pollen by Collateral Priming in a Murine Model of Allergic Respiratory Disease
Cadot, P., Meyts, I., Vanoirbeek, J., Vanaudenaerde, B. M., Bullens, D. M. A., & Ceuppens, J. L. (2010) · International Archives of Allergy and Immunology · doi:10.1159/000283031 · Cited by 8
Qualität in der Allergologie
Wagenmann, M., Stenin, I., & Scheckenbach, K. (2020) · Laryngo-Rhino-Otologie · doi:10.1055/a-1029-6494 · Cited by 7
Allergen-specific immunotherapy. Analytic review of current international and Russian federal position papers
Kurbacheva, O. M., Pavlova, K. S., & Galitzkaya, M. A. (2017) · Russian Journal of Allergy · doi:10.36691/rja333 · Cited by 7
Die Cluster-Immuntherapie bei der persistierenden allergischen Rhinitis
Pfaar, O., Mösges, R., Hörmann, K., & Klimek, L. (2009) · HNO · doi:10.1007/s00106-009-1946-8 · Cited by 7
New insights in sublingual immunotherapy
Passalacqua, G., Guerra, L., Compalati, E., Fumagalli, F., Cirillo, A., & Canonica, G. W. (2006) · Current Allergy and Asthma Reports · doi:10.1007/s11882-996-0014-7 · Cited by 7
Die spezifische Immuntherapie (Hypo- sensibilisierung) bei IgE-vermittelten allergischen Erkrankungen Leitlinie der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA) und der Gesellschaft für pädiatrische Allergologie und Umwelt- medizin (GPA)
Kleine‐Tebbe, J., Bergmann, K., Friedrichs, F., Fuchs, T., Jung, K., Klimek, L., Kühr, J., Lässig, W., Lepp, U. S., Niggemann, B., et al. (2006) · Cited by 7
Mucosal Immunity and Sublingual Immunotherapy in Respiratory Disorders
Bahçeciler, N. N. (2012) · Journal of Allergy · doi:10.1155/2012/725719 · Cited by 6
Timothy Grass Pollen Therapeutic Vaccine: Optimal Dose for Subcutaneous Immunotherapy
Sola, J., Ferreira, J. A., Elera, J. D., Plácido, J. L., Pereira, C., Fonseca, J., Panizo, C., Inácio, L. F., Cancelleire, N., Zubeldia, J. M., et al. (2016) · Immunotherapy · doi:10.2217/imt.15.125 · Cited by 6
Food-specific sublingual immunotherapy is well tolerated and safe in healthy dogs: a blind, randomized, placebo-controlled study
Maina, E., Pelst, M. P., Hesta, M., & Cox, E. (2016) · BMC Veterinary Research · doi:10.1186/s12917-017-0947-1 · Cited by 6
A Real-World Effectiveness of Subcutaneous Immunotherapy on the Cost of Medication, Allergic Rhinitis, and Asthma Exacerbations, as well as Upper Respiratory Tract Infection in Subjects with Allergic Rhinitis with or without Asthma: A Retrospective Pilot Study
Pothirat, C., & Chaiwong, W. (2021) · Medicina · doi:10.3390/medicina57111229 · Cited by 6
Comparison of short-term effects between subcutaneous and sublingual immunotherapies in children with house dust mite-sensitized allergic rhinitis and asthma
Lee, E., Kim, M.-J., Yang, S., Yu, J., & Hong, S. (2015) · Allergy Asthma & Respiratory Disease · doi:10.4168/aard.2015.3.3.180 · Cited by 6
Local Immunotherapy in Allergy: Prospects for the Future
Markert, U. R. (2003) · KARGER eBooks · doi:10.1159/000071547 · Cited by 6
Prévention secondaire et tertiaire de l’asthme allergique de l’enfant
Rancé, F., Deschildre, A., Bidat, É., Just, J., Couderc, L., Wanin, S., & Weiss, L. M. (2009) · Revue française d'allergologie · doi:10.1016/j.reval.2009.10.003 · Cited by 6
Practical management of immunotherapy
Álvarez-Cuesta, E., & Beristain, A. (2003) · Revue Française d Allergologie et d Immunologie Clinique · doi:10.1016/s0335-7457(03)00194-1 · Cited by 5
Natural History of Allergic Diseases and Asthma
Liu, A. H., & Martínez, F. D. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-29875-9.00002-1 · Cited by 5
Allergen Immunotherapy for a Teenager with Seasonal Allergic Rhinitis Due to Grass Pollen: Subcutaneous or Sublingual Route?
Nelson, H. S., & Durham, S. R. (2017) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2016.10.012 · Cited by 5
Spezifische Immuntherapie bei IgE-vermittelten allergischen Erkrankungen im Kindes- und Jugendalter – eine Übersicht über in Österreich zugelassene/registrierte Allergenpräparate
für die Österreichische Gesellschaft für Kinder, J., Szépfalusi, Z., Emminger, W., Eitelberger, F., Götz, M., Grillenberger, A., Horak, E., Huttegger, I., Koller, D. Y., Litscher, H., et al. (2009) · Wiener klinische Wochenschrift · doi:10.1007/s00508-009-1258-8 · Cited by 5
Preventive capacity of subcutaneous immunotherapy
Valovirta, E. J. (2002) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200212000-00013 · Cited by 5
The Prevention of New Sensitizations by Specific Immunotherapy: A Long-Term Observational Case Control Study
Bożek, A. (2014) · Journal of Allergy & Therapy · doi:10.4172/2155-6121.1000182 · Cited by 4
Safety evaluation of rapid build-up schedules with IR-standardized allergen extracts for subcutaneous immunotherapy of allergic respiratory diseases
Fernández-Távora, L., Justicia, J. L., Moreno, C., Tabar, A. I., & Vidal, C. (2011) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2011.603724 · Cited by 4
Die spezifische Immuntherapie (Hyposensibilisierung) mit Allergenen zwischen wissenschaftlichem Fortschritt und medizinischer Versorgungsrealität
Kleine‐Tebbe, J., Ackermann-Simon, J., & Hanf, G. (2012) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-011-1433-8 · Cited by 4
Stellenwert und Indikation der SLIT im Vergleich zur SCIT
Wedi, B. (2008) · Der Hautarzt · doi:10.1007/s00105-008-1491-5 · Cited by 4
Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist
Bernstein, D. I., Blaiss, M. S., Cox, L., Finegold, I., Lanier, B. Q., Nelson, H. S., & Wallace, D. V. (2011) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2011.05.026 · Cited by 4
Early detection of allergic diseases in otorhinolaryngology
Klimek, L., & Schendzielorz, P. (2008) · PubMed Central · doi:10.3205/cto000049 · Cited by 4
Actual therapeutic management of allergic and hyperreactive nasal disorders.
Rudack, C. (2004) · PubMed Central · Cited by 4
House Dust Mite Immunotherapy in Iraqi Patients with Allergic Rhinitis and Asthma
Mohamad, A., Alobaidi, A. H. A., Mezher, S., & Mohamed, A. (2012) · InTech eBooks · doi:10.5772/47942 · Cited by 4
Allergie aux acariens domestiques : du diagnostic à la prise en charge
Dutau, G. (2014) · Revue française d'allergologie · doi:10.1016/j.reval.2014.10.003 · Cited by 4
Strategies for preventing allergic disease
Grimshaw, K. E. C., & Warner, J. O. (2005) · Current Paediatrics · doi:10.1016/j.cupe.2005.02.005 · Cited by 4
Natural History of Allergic Diseases and Asthma
Liu, A. H., Martínez, F. D., & Taussig, L. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4377-0271-2.00002-x · Cited by 4
Allergen immunotherapy: Current and new therapeutic strategies
Rolland, J. M., & O’Hehir, R. E. (2002) · Allergology International · doi:10.1046/j.1440-1592.2002.00272.x · Cited by 4

Authors: Purello‐D'Ambrosio, F., Gangemi, S., Merendino, R. A., Isola, S., Puccinelli, P., Parmiani, S., & Ricciardi, L.
Affiliations: University of Messina (IT)
ALK-Abelló (Italy) (IT)
Corresponding author: Gangemi, S.
ORCID: Gangemi, S.
Ricciardi, L.
Venue: Clinical & Experimental Allergy
Publisher: Wiley
Published: 2001-08
Volume: 31
Issue: 8
Pages: 1295-1302
ISSN: 0954-7894 (ISSN-L)
1365-2222
DOI: 10.1046/j.1365-2222.2001.01027.x
OpenAlex: W2085196853
Cited by: 281
References: 76
Citations by year: 2026: 1 · 2025: 1 · 2024: 4 · 2023: 4 · 2022: 7 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 12 · 2017: 13 · 2016: 16 · 2015: 14 · 2014: 17 · 2013: 9 · 2012: 14
FWCI: 5.74
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 164 d)
Locations: Clinical & Experimental Allergy (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
Keywords: allergen immunotherapy, polysensitization, allergic respiratory diseases, asthma, allergic rhinitis, antiallergic drugs, specific IgE, total IgE, allergen sensitization
MeSH terms: Contraindications, Administration, Inhalation, Administration, Oral, Adult, Allergens, Epitopes, Asthma, Desensitization, Immunologic, Drug Administration Schedule, Female, Follow-Up Studies, Histamine H1 Antagonists, Humans, Hypersensitivity, Delayed, Immunoglobulin E, Italy, Male, Retrospective Studies, Rhinitis, Receptors, Adrenergic, beta-2, Anti-Allergic Agents, Adrenergic beta-2 Receptor Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks